ConductScience.org, home

Paper698917

Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.

Falkson HC and 4 others. Cancer, 1978. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy. Papers, record 698917. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/698917

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.
PubMed
Journal
Cancer
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.67
iCite
Revised in PubMed
2019-06-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Falkson HCH C
2Van Der Watt JJJ J
3Portugal MAM A
4Pitout MJM J
5Falkson GG

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Carcinoembryonic AntigenMajor topic
Antineoplastic Agents
False Negative Reactions
Female
Humans
Immunotherapy
Neoplasm Metastasis
Recurrence
Remission, Spontaneous
Time Factors

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
39742378Comparison of BRCA1 Gene Expression and CA15-3 Tumor Marker Level in Different Stages of Breast Cancer.Breast J2024https://conductscience.org/library/papers/39742378PubMed
8727945Serum tumor marker kinetics and the clinical course of patients with advanced breast cancer.Surg Today1996https://conductscience.org/library/papers/8727945PubMed
7579505Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients.Breast Cancer Res Treat1995https://conductscience.org/library/papers/7579505PubMed
6756459The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.Br J Cancer1982https://conductscience.org/library/papers/6756459PubMed
4066982Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes.J Clin Pathol1985https://conductscience.org/library/papers/4066982PubMed
3762017[Diagnostic validity of CEA determination in metastasizing breast cancer].Klin Wochenschr1986https://conductscience.org/library/papers/3762017PubMed
2358858Plasma carcinoembryonic antigen as an indicator of cerebral metastases.J Neurooncol1990https://conductscience.org/library/papers/2358858PubMed
1878893Prospective assessment of the role of five tumour markers in breast cancer.Cancer Immunol Immunother1991https://conductscience.org/library/papers/1878893PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/698917

GET https://conductscience.org/api/papers/v1/698917/authors